濮阳东方男科医院割包皮手术安全濮阳东方男科非常可靠,濮阳东方医院妇科咨询专家,濮阳东方男科口碑比较好,濮阳东方医院男科咨询中心,濮阳市东方医院口碑好价格低,濮阳东方男科比较好,濮阳东方医院看男科病非常好

Actress Roseanne Barr threw Twitter off the rails late Friday after she tweeted her support of a right-wing conspiracy theory."President Trump has freed so many children held in bondage to pimps all over this world. Hundreds each month. He has broken up trafficking rings in high places everywhere. notice that. I disagree on some things, but give him benefit of doubt-4 now," she tweeted. 397

All Coca-Cola needed to do to rejuvenate Diet Coke was add some Feisty Cherry, Twisted Mango, Ginger Lime and Zesty Blood Orange. In skinny cans.Diet Coke posted sales volume growth in North America during the first quarter, thanks in large part to those four new flavors. Coca-Cola said it was the first time Diet Coke's volume had risen in the United States and Canada since late 2010.The new Diet Coke flavors, introduced in January, were "bold enough and interesting enough" to attract more Millennials and people who prefer flavored sparkling water to soda, CEO James Quincey said.The long slump in Diet Coke sales is partly because of the popularity of LaCroix, a sparkling water brand owned by National Beverage. Coca-Cola is looking to gain ground in that market: It bought the rights to sell the Mexican mineral water Topo Chico in the United States last October.But consumers, especially Millennials, have also turned away from diet soda in favor of healthier options.Quincey, who took over as CEO of Coke last May from longtime chief Muhtar Kent, said in February that Coke needs to shake things up if it wants to attract younger customers. The new Diet Coke flavors are an example of that."We've got to experiment, which means learning from the tech industry, the 1.0, the 2.0, the 3.0. Don't make it perfect, get something out there, learn, and make it better," Quincey told Harlow.Coke has been busy with other newish products. It rebranded Coke Zero as Coke Zero Sugar — and that subtle change also seems to be working. Sales rose at a double-digit pace in the quarter. Tea and coffee sales were up 5%, too.Wall Street wasn't impressed with Coke's results, though. Even though overall sales and profits topped forecasts, the stock fell nearly 2% on Tuesday. Shares are down 6% this year.Pablo Zuanic, an analyst at Susquehanna Financial Group, noted that lower pricing in North America may have helped boost sales. And Wall Street may not be pleased with that. He said he expected the stock to "tread water" as a result.For the past five years, Coke's stock has lagged top rival Pepsi, which also owns a thriving snack food business, and Dr Pepper Snapple, which recently agreed to sell itself to the coffee giant Keurig Green Mountain. 2259

All I can say is WOW! My mom and my sisters threw me the most epic surprise party that was so special in my heart. We showed it on E as a special so you guys got to see the behind the scenes of how it really went down. pic.twitter.com/cJ90quZD3U— Kim Kardashian West (@KimKardashian) October 23, 2020 308

After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.All U.S. testing sites are legally required to report their results, positive and negative, to public health agencies. But state health officials say many rapid tests are going unreported, which means some new COVID-19 infections may not be counted.And the situation could get worse, experts say. The federal government is shipping more than 100 million of the newest rapid tests to states for use in public schools, assisted living centers and other new testing sites.“Schools certainly don’t have the capacity to report these tests,” said Dr. Jeffrey Engel of the Council of State and Territorial Epidemiologists. “If it’s done at all it’s likely going to be paper-based, very slow and incomplete.”Early in the outbreak, nearly all U.S. testing relied on genetic tests that could only be developed at high-tech laboratories. Even under the best circumstances, people had to wait about two to three days to get results. Experts pushed for more “point-of-care” rapid testing that could be done in doctors offices, clinics and other sites to quickly find people who are infected, get them into quarantine and stop the spread.Beginning in the summer, cheaper, 15-minute tests — which detect viral proteins called antigens on a nasal swab — became available. The first versions still needed to be processed using portable readers. The millions of new tests from Abbott Laboratories now going out to states are even easier to use: they’re about the size of a credit card and can be developed with a few drops of chemical solution.Federal health officials say about half of the nation’s daily testing capacity now consists of rapid tests.Large hospitals and laboratories electronically feed their results to state health departments, but there is no standardized way to report the rapid tests that are often done elsewhere. And state officials have often been unable to track where these tests are being shipped and whether results are being reported.In Minnesota, officials created a special team to try and get more testing data from nursing homes, schools and other newer testing sites, only to be deluged by faxes and paper files.“It’s definitely a challenge because now we have to do many more things manually than we were with electronic reporting,” said Kristen Ehresmann, of the Minnesota Department of Health.Even before Abbott’s newest BinaxNOW rapid tests hit the market last month, undercounting was a concern.Competitors Quidel and Becton Dickinson have together shipped well over 35 million of their own quick tests since June. But that massive influx of tests hasn’t showed up in national testing numbers, which have mostly ranged between 750,000 and 950,000 daily tests for months.Besides tallying new cases, COVID-19 testing numbers are used to calculate a key metric on the outbreak: the percentage of tests positive for COVID-19. The World Health Organization recommends countries test enough people to drive their percent of positives below 5%. And the U.S. has mostly been hovering around or below that rate since mid-September, a point that President Donald Trump and his top aides have touted to argue that the nation has turned the corner on the outbreak. The figure is down from a peak of 22% in April.But some disease-tracking specialists are skeptical. Engel said his group’s members think they aren’t getting all the results.“So it may be a false conclusion,” he said.One of the challenges to an accurate count: States have wildly different approaches. Some states lump all types of tests together in one report, some don’t tabulate the quick antigen tests at all and others don’t publicize their system. Because antigen tests are more prone to false negatives and sometimes require retesting, most health experts say they should be recorded and analyzed separately. But currently the vast majority of states do not do that and post the results online.The federal government is allocating the tests to states based on their population, rather than helping them develop a strategy based on the size and severity of their outbreaks.“That’s just lazy” said Dr. Michael Mina of Harvard University. “Most states won’t have the expertise to figure out how to use these most appropriately.”Instead, Mina said the federal government should direct the limited test supplies to key hot spots around the country, driving down infections in the hardest-hit communities. Keeping tighter control would also ensure test results are quickly reported.Johns Hopkins University researcher Gigi Gronvall agrees health officials need to carefully consider where and when to deploy the tests. Eventually, methods for tracking the tests will catch up, she said.“I think having the tools to determine if someone is infectious is a higher priority,” she said.___AP data journalist Nicky Forster contributed to this story___Follow Matthew Perrone on Twitter: @AP_FDAwriter___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5285

After briefly becoming a Category 2 storm on Monday, Hurricane Sally weakened back to a Category 1 storm overnight as it threatens to swamp Mississippi, Alabama, and the Florida panhandle.In its 8 p.m. CT update, the National Hurricane Center said Tuesday that Sally currently has maximum sustained winds of 85 mph and is currently moving toward the Mississippi and Alabama shores at 2 mph.The NHC said the hurricane is about 70 miles south of Mobile, Alabama, and 70 miles southwest of Pensacola, Florida.At 9 p.m. CT, a sustained wind of 58 mph with a gust of 73 mph was reported at Petit Bois Island, Mississippi, the NHC said.The overnight weakening is a welcome sign to forecasters. On Monday evening, NHC forecasted that Sally could produce winds of up to 110 mph before it made landfall.NHC warned that even though the storm slowed down, it will still produce a "life-threatening" storm surge in the central Gulf Coast region of the U.S. The NHC says "historic" flash flooding is possible as it makes landfall.The agency expects the Alabama coast to see the most flooding, including Mobile Bay.Hurricane conditions are expected as early as Tuesday, and the storm is currently projected to make landfall by Wednesday morning. 1239